SafeHeal® Closes Oversubscribed €35 Million Series C Equity Financing
Proceeds will support the completion of SafeHeal's IDE pivotal study and preparation for commercial launch of their lead technology , Colovac®.
SafeHeal®, a leading innovator in the field of colorectal cancer surgery, today announced a successful completion of an oversubscribed €35 million Series C equity financing to validate the use of Colovac®, a groundbreaking temporary endoluminal fecal bypass system. Colovac is intended as an alternative to temporary diverting ostomy for patients undergoing colorectal cancer resection.
The proceeds leave SafeHeal well-funded to complete its IDE Pivotal study and accelerate preparation for commercial launch of their lead technology, Colovac.
In conjunction with the financing, Martin Sands and Steven Sands of Solar Eclipse will join as board member and observer respectively.
The Colovac endoluminal bypass system is a less-invasive alternative to temporary diverting ostomy, the current standard of care for patients undergoing colorectal resection. Diverting ostomy is applied prophylactically to most patients today undergoing a low anterior resection (LAR) and anastomosis. The ostomy temporarily diverts the stool away from the healing anastomosis to the outside of the body and into an ostomy bag. In most cases, the ostomy is needed only until the anastomosis has healed, and then it can be reversed, typically after 2-6 months. The eventual reversal of the ostomy requires another operation, with a second hospital stay, recovery period and associated complications. In some cases, the ostomy may not be reversed and becomes permanent. In addition to the potential surgical complications associated with ostomy procedures, patients may experience an impact to their quality of life due to social isolation, reduced physical activity and/or intimacy.
Colovac is an alternative to diverting ostomy, designed to eliminate the need for a temporary stoma in most patients. It aims to improve patient recovery and quality of life by eliminating stoma related complications including permanent stoma and eliminating the physical and emotional burden associated with stoma management and care.
Colovac has been successfully studied in over 100 patients in the U.S., Europe, and Asia and has received FDA Breakthrough Designation status.
'This is a very exciting time at SafeHeal as we continue to achieve a number of critical value-creating milestones in the coming months,' said Chris Richardson, President and Chief Executive Officer. 'We are grateful for the continuing support from Sofinnova Partners and delighted to welcome Solar Eclipse, Gideon and M&L Healthcare, part of M&L Group as new investors. This capital raise places SafeHeal in an excellent position to continue our momentum toward FDA approval and commercialization of Colovac.'
Chris Richardson, President & CEO, SafeHeal
'The current standard of care for treatment of Colon Resection is associated with significant morbidity, risk of permanent stoma and reduced quality of life, driving both the clinical community and regulators to search for better treatment options. SafeHeal is addressing this significant unmet medical need with a highly novel approach,' said Martin Sands of Solar Eclipse. 'I believe SafeHeal's therapeutic platform will dramatically improve quality of life and outcomes for patients with Colon Resections. I look forward to supporting the team to achieve multiple key milestones over the next 18 months.'
'We've been with SafeHeal since day one, when it was born out of our Medtech accelerator, MDStart. Our continued support in this Series C reflects a deep growing belief in their potential to revolutionize care for patients facing ostomy,' said Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners.
ABOUT SAFEHEAL®
SafeHeal SAS, headquartered in Paris, France, and its wholly owned U.S. subsidiary, SafeHeal Inc., is a clinical-stage medical device company developing Colovac, a device intended as an alternative to diverting ostomy in patients undergoing colorectal surgery. Colovac is a flexible endoluminal bypass sheath designed to reduce the contact of fecal content at the anastomotic site following colorectal surgery. The device is placed endoluminally and is fully reversible. The device remains in place for 7-10 days, until the body's natural healing and tissue repair processes are complete, after which it is removed during an endoscopic procedure without the need for a second surgical intervention. This enables patients to resume their normal life without the stigma and complications associated with an ostomy procedure. Colovac is an investigational device, not currently available for sale. For more information, please visit www.safeheal.com
MEDIA CONTACTS
USA
Scott DePierro
Vice President U.S. Operations
and Global Business Development, SafeHeal
203-444-0279
[email protected]
www.safeheal.com
Europe:
Karl-Heinz Blohm
Vice President, International, SafeHeal
+33 (0) 6 5181 7895
[email protected]
www.safeheal.com
###
Scott DePierro, VP US Operations & Global Business Dev
SafeHeal
+1 203-444-0279
email us here
Visit us on social media:
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
The 5 Best Cereals to Reduce Stroke Risk, According to Cardiologists and Dietitians
Reviewed by Dietitian Maria Laura Haddad-Garcia Cardiovascular disease (CVD) and stroke are among the leading causes of death and disability in the United States. While genetics and lifestyle play a role, diet is a key player in stroke prevention—and your morning cereal can help tip the scales in your favor. "A high-fiber, low-sodium diet can help to promote optimal blood sugar, blood pressure and cholesterol levels, which can reduce the risk of plaque formation, hypertension, diabetes and stroke," says Bhavna Suri, M.D, a cardiologist. While breakfast cereals are a quick and easy choice, not all are made the same. Many are packed with added sugar and lack fiber—two strikes against stroke prevention. Instead, look for cereals that are low in added sugars and sodium, high in fiber and made with whole grains. Here are five of the best cereals, approved by heart-health experts, that can reduce your risk of stroke. Plus: tips on building a stroke-smart breakfast. 1. Shredded Wheat (Unfrosted) When it comes to heart-healthy cereals, Post Shredded Wheat Original Spoon Size® cereal stands out. "When looking for a cereal to reduce your stroke risks, generally, you are looking for one that is high in fiber and low in added sugar," says Abigail Nessle, RDN, LDN. This option checks those boxes, with one serving (1 ⅓ cup) providing 8 grams of fiber, which is 28% of the Daily Value. It also contains essential nutrients, including iron, niacin, phosphorus, magnesium and zinc. Magnesium, in particular, has been shown to protect against stroke risk (particularly in women), though more research is needed. Plus, Post Shredded Wheat is sodium-free—a big win for a heart-healthy diet. Most Americans consume significantly more sodium than the recommended daily intake of 2,300 mg per day, with average intake exceeding 3,000 mg. Reducing sodium intake can help lower your blood pressure and reduce your risk of cardiovascular disease and stroke. 2. Cascadian Farm Organic No Added Sugar Cereals Added sugars are a sneaky contributor to cardiovascular disease and stroke risk. Breakfast cereals are a common source of added sugar, even in those labeled as healthy due to their high fiber or whole grain content. Cascadian Farm Organic No Added Sugar offers a tasty solution. It comes in two flavors—Vanilla Crisp and Mixed Berry—so you have a choice to fit your preferences. Each 1 ¼-cup serving offers 5 g of protein and 5-6 (depending on the flavor) g of fiber—two nutrients that contribute to increased feelings of satiety. Plus: "One of the many superpowers of fiber is to help block the absorption of cholesterol that can turn into plaque in the veins and arteries," says Nessle. When cholesterol is elevated, blood flow can be blocked, resulting in a type of stroke called an ischemic stroke. One caveat: Both flavors are higher in sodium than what many dietitians recommend for a stroke-smart breakfast, with 390-400 mg per serving. Karen E. Todd, RD, CSCS, EP-C, CISSN, suggests choosing a cereal with less than 140 mg of sodium per serving. Modifying the portion size or reducing sodium in other meals can help keep your total daily intake within recommended limits. 3. Post Grape-Nuts The Original Upping your daily fiber is easy if you choose Post Grape-Nuts The Original as your morning cereal. Just one 1 ½-cup serving offers 7 g of fiber and zero added sugar, along with iron, folate, vitamin B6, niacin, thiamin, zinc and phosphorus. Some research suggests that folic acid supplementation may lower stroke risk, though supplements can have varied effects depending on individual health conditions. That's why food sources like Grape-Nuts are ideal for getting these nutrients. 4. Old-Fashioned Rolled Oats A classic for a reason, oats are a heart-healthy, high-fiber choice that makes a great addition to a stroke-smart breakfast. "Packed with 4-5 grams of fiber per ½ cup, [oats] lower cholesterol with beta-glucans and keep blood sugar steady,' says Todd. Beta-glucan, a component of soluble fiber found in oats, is especially beneficial for reducing cholesterol in the blood. Optimal dietary fiber intake also helps support a healthy weight, thereby reducing the risk of certain chronic diseases, such as cardiovascular disease. For added fiber and antioxidants, stir in chia seeds or top with fresh berries. 5. Bran Cereals Bran cereals are another fiber-rich pick, typically offering 5 to 7 g of fiber per serving. Many are also fortified with key vitamins and minerals, such as iron and vitamin D. Bran cereal may help manage blood pressure, cholesterol, and blood sugar—all critical factors in reducing the risk of cardiovascular disease. Just be sure to check the Nutrition Facts label—some brands sneak in more than 200 mg of sodium per serving. How to Build a Stroke-Smart Breakfast Building a stroke-smart breakfast means paying close attention to a few key nutrients. When choosing a morning cereal, Todd recommends avoiding those that are high in added sugar or sodium, as well as refined-grain cereals and instant oatmeal packets with added sugars. Here's how to round out your morning meal for better heart health: Add Fruits or Vegetables Potassium-rich foods, such as fruits and veggies, support heart health and are often missing from breakfast. "A 2023 review of more than 25 studies found that a diet rich in fruits and vegetables earlier in life may lower stroke risk compared with meat and fat intake," says Brittany Brown, RD, IBCLC, CDE. Try blending leafy greens like spinach into a smoothie or topping your bowl of cereal with fresh berries. Limit Sodium Some common breakfast choices—like breakfast meats, biscuits and some processed cereals—are high in sodium. "Diets high in salt can increase your blood pressure and risk of stroke," says Suri. Aim to stay under 2,300 mg of sodium daily (ideally closer to 1,500 mg) for heart protection. Cut Back on Added Sugar While added sugar is found in obvious foods like pastries, tarts and muffins, it often sneaks into less obvious ones as well. Be sure to check the nutrition facts label when looking for a breakfast option. And limiting sugar doesn't mean that you can't satisfy your sweet tooth; Todd recommends turning to naturally sweet foods like fruit and unsweetened dairy products. Incorporate Healthy Fats "Some cereals contain nuts and flax seeds, which can improve our levels of good HDL cholesterol," says Suri. Add in walnuts, almonds, chia or hemp seeds for more heart health benefits. Our Expert Take "Your plate is a powerful tool for stroke prevention," says Todd. And if you're choosing cereal, then your bowl is too. A breakfast cereal made from whole grains, with minimal sugar and sodium, can become a daily opportunity to protect your health—starting with your heart. Don't forget to boost your bowl with extras like fruit, seeds and nuts to enhance the fiber and nutrient profile. Read the original article on EATINGWELL
Associated Press
4 hours ago
- Associated Press
T-NeuroDx to Present Advances in Blood Test for Early Alzheimer's Detection at Major Conference
'We believe that studying the body's adaptive immune system will play a pivotal role in the early detection of Alzheimer's'— Dr. Wheeler ALBUQUERQUE, NM, UNITED STATES, July 27, 2025 / / -- T-NeuroDx, a company pioneering new diagnostic tools that use abnormalities in the immune system to detect Alzheimer's Disease, will present its latest research at the 2025 Alzheimer's Association International Conference (AAIC) in Toronto, Canada, from July 27–31. Dr. Christopher Wheeler, the company's Chief Science Officer, will share new findings about the company's promising blood test for Alzheimer's. The research focuses on identifying specific aged immune cells in the blood that act as an early warning sign, or 'biomarker,' for the disease. A significant breakthrough in this new study is the enhancement of the test to be effective for all Alzheimer's patients, a critical step toward making this technology widely available. This builds upon Dr. Wheeler's initial discovery of the biomarker announced last year . 'We believe that studying the body's adaptive immune system will play a pivotal role in the early detection of Alzheimer's,' said Dr. Wheeler. 'Our results strengthen our case for a scalable, blood-based diagnostic that can move us closer to timely intervention and improved outcomes.' T-NeuroDx's vision is to create simple, accessible blood tests that can help doctors diagnose Alzheimer's sooner, allowing for earlier treatment and better patient care. Presentation Details: • Poster Title: #107315 - Levels of age-related blood CD8 T cells binding a non-self peptide/HLA epitope track with Alzheimer's disease status in HLA-A2+ and HLA-A2- cohorts: a T cell biomarker assay applicable to all patients. • Session: Biomarkers (non-neuroimaging) track. • Event: Alzheimer's Association International Conference (AAIC) 2025 • Date: Monday, July 28, 2025 • Time: 7:30 AM – 4:15 PM EDT • Location: Toronto, Canada For more information about T-NeuroDx, please visit John Chavez T-NeuroDx +1 505-660-1046 [email protected] Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Washington Post
6 hours ago
- Washington Post
As state battles intensify, what's next for abortion pill access in U.S.?
The battle for abortion access in America, now concentrated in pharmacies and mailboxes, is headed toward a new reckoning in the nation's federal courthouses. Since the fall of Roe v. Wade three years ago, the number of abortions counted annually in the United States has risen, thanks largely to the growing availability of mifepristone and misoprostol. Medication abortions account for almost two-thirds of terminations involving a clinician, recent studies show — a 10-percentage-point leap from 2020.
